Search research articles
Contact Us
Filters
Showing results (301-310 of 339) with videos related to
Page
of 34
Sort By:
Blood
|
August 1, 2002
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome
H Joachim Deeg, Barry Storer, John T Slattery, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 30, 2009
Acute myeloid leukemia
Margaret R O'Donnell, Frederick R Appelbaum, Steven E Coutre, et al.
British Journal of Haematology
|
July 9, 2013
A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia
Fabiana Ostronoff, Megan Othus, Hagop M Kantarjian, et al.
Blood
|
November 30, 2016
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu Estey, David Grimwade, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 12, 2011
Acute myeloid leukemia
Margaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Blood
|
August 16, 2003
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
H Joachim Deeg, Theodore A Gooley, Mary E D Flowers, et al.
Blood
|
August 12, 2024
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations
Hartmut Döhner, Courtney D DiNardo, Frederick R Appelbaum, et al.
Leukemia
|
August 3, 2022
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
Nikolaus Jahn, Ekaterina Jahn, Maral Saadati, et al.
Blood
|
July 7, 2022
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Hartmut Döhner, Andrew H Wei, Frederick R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 339) with videos related to
Sort By:
Page
of 34
Blood
|
August 1, 2002
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome
H Joachim Deeg, Barry Storer, John T Slattery, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 30, 2009
Acute myeloid leukemia
Margaret R O'Donnell, Frederick R Appelbaum, Steven E Coutre, et al.
British Journal of Haematology
|
July 9, 2013
A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia
Fabiana Ostronoff, Megan Othus, Hagop M Kantarjian, et al.
Blood
|
November 30, 2016
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu Estey, David Grimwade, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 12, 2011
Acute myeloid leukemia
Margaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Blood
|
August 16, 2003
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
H Joachim Deeg, Theodore A Gooley, Mary E D Flowers, et al.
Blood
|
August 12, 2024
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations
Hartmut Döhner, Courtney D DiNardo, Frederick R Appelbaum, et al.
Leukemia
|
August 3, 2022
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
Nikolaus Jahn, Ekaterina Jahn, Maral Saadati, et al.
Blood
|
July 7, 2022
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Hartmut Döhner, Andrew H Wei, Frederick R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Page
of 34